2026 NPPES data Hematology & Oncology Physician NPI 1104850841 MD
Verify on CMS →

John Garofalo, MD

Hematology & Oncology Physician in Bryn Mawr, Pennsylvania.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
22
Medicare Part D claims · Hematology & Oncology Physician avg: 847

What the federal data shows

John Garofalo, MD filed 22 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Bryn Mawr, Pennsylvania.

22
Part D claims, 2023
≥0th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

CMS NPPES provider registry desk

NPI 1104850841 · Hematology & Oncology Physician

NPI-10 · ENUM-LEGACY · TAX-MID · RX-TRACE · BOOK-LIGHT · PHOTO-ENUM

  • NPI-10 1104850841
  • ENUM-LEGACY 2006
  • TAX-MID 11K Hematology &
  • RX-TRACE 22
  • BOOK-LIGHT 636 in Pennsylvania
  • PHOTO-ENUM Alexander Black · 2006

John Garofalo, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

22 ≥ 0th percentile 0% of 1,370,886 prescribers are in lower value bands

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

John Garofalo, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about John Garofalo, MD?

Quality data not reported

NPI registry status

Active

Issued 07/10/2006

NPI 1104850841

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,232 US NPIs in this specialty

Medicare Part D claims

22 97% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Pennsylvania

How Hematology & Oncology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers
Student in an Organized Heal…5.6%Pharmacist5%Physical Therapist4.9%Mental Health Counselor3.9%Internal Medicine Physician3.3%Professional Counselor3.2%Hematology & Oncology Physic…0.2%
Largest specialties in Pennsylvania (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

847 OLD LANCASTER ROAD
Bryn Mawr, PA 19010

Provider Details

NPI 1104850841
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 07/10/2006

License & disciplinary context - Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to John Garofalo, MD. To verify John Garofalo, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

22
Total Claims
$319
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
40
Total Day Supply
1,032
Generic Drug Cost
$285

Patient Demographics

Average Patient Age
79.7 years
Avg HCC Risk Score
1.58

Hematology & Oncology Physician Overview

How John Garofalo, MD fits within the Hematology & Oncology Physician landscape nationally.

11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

John Garofalo, MD's 22 claims are below the specialty average of 847.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Garofalo, both outside Pennsylvania so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Garofalo.

One of 636 Hematology & Oncology Physician providers enrolled in Pennsylvania, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is John Garofalo, MD's specialty?
John Garofalo, MD specializes in Hematology & Oncology Physician and practices in Bryn Mawr, Pennsylvania. Credentials: MD.
How much does John Garofalo, MD prescribe under Medicare Part D?
In 2023, John Garofalo, MD wrote 22 Medicare Part D claims totaling $319 in drug costs for N/A beneficiaries.
Where is John Garofalo, MD located?
John Garofalo, MD is located at 847 OLD LANCASTER ROAD, Bryn Mawr, PA, 19010. Phone: (610) 527-1290.
What is John Garofalo, MD's NPI number?
John Garofalo, MD's National Provider Identifier (NPI) is 1104850841, issued on 07/10/2006.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
Does John Garofalo, MD accept Medicare?
John Garofalo, MD appears in CMS Medicare data with 22 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify John Garofalo, MD's credentials?
John Garofalo, MD's NPI is 1104850841 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.